Completed NA INTERVENTIONAL 2-arm NCT01340222

Monocyte Chemotactic Protein-1 (MCP-1) Expressing Monocytes to Predict Preterm Delivery: PhenoMAP Study (PHENOMAP)

Evaluation of the Prognostic Value of Monocytes and Lymphocyte Phenotyping, Along With Intracellular MCP-1 Expression, to Predict Preterm Delivery for Women Hospitalized for Threat of Preterm Labor Between 24 and 34 Weeks of Amenorrhea: PhenoMAP Study

Sponsor: Centre Hospitalier Universitaire Dijon

Conditions Preterm Labour

Interventions biological samples

Updated 8 times since 2017 Last updated: Feb 5, 2026 Started: Mar 31, 2011 Primary completion: Jul 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01340222, this NA trial focuses on Preterm Labour and remains completed. Sponsored by Centre Hospitalier Universitaire Dijon, it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Feb 2026 — Present [monthly]

Completed NA
Sep 2024 — Feb 2026 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Mar 2024 [monthly]

Completed NA

▶ Show 3 earlier versions

Jan 2019 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Jun 2018 — Jan 2019 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire Dijon

Data source: Centre Hospitalier Universitaire Dijon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dijon, France